1887

Abstract

Glycoprotein B (gB) is the most conserved glycoprotein among herpesviruses and it plays important roles in virus infectivity. In most herpesviruses, including pseudorabies virus (PRV), gB is cleaved by a cellular protease into two disulfide-linked subunits. In the present study, I found that the PRV gB generated in human colon carcinoma LoVo cells, which lack the ubiquitous protease furin, remained in the uncleaved form and the virus replicated in these cells without cell fusion. The uncleaved gB was converted into its subunits after furin digestion. The virus also replicated in Madin–Darby bovine kidney cells without cell fusion in the presence of a furin inhibitor, whereas distinct syncytia were formed in the absence of the inhibitor. LoVo cells constitutively expressing furin showed cell fusion when they were infected with the virus. Penetration kinetics assays revealed that the virus carrying uncleaved gB penetrated the cells at the same rate as the virus carrying cleaved gB. These results indicate that PRV gB is cleaved by furin and that the cleavage is dispensable for virus replication . Furthermore, gB cleavage is involved in syncytium formation but not in penetration kinetics, suggesting that different mechanisms operate between cell–cell fusion and virus–cell fusion by PRV.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.82610-0
2007-07-01
2024-04-28
Loading full text...

Full text loading...

/deliver/fulltext/jgv/88/7/1859.html?itemId=/content/journal/jgv/10.1099/vir.0.82610-0&mimeType=html&fmt=ahah

References

  1. Baghian A., Luftig M., Black J. B., Meng Y. X., Pau C. P., Voss T., Pellett P. E., Kousoulas K. G. 2000; Glycoprotein B of human herpesvirus 8 is a component of the virion in a cleaved form composed of amino- and carboxyl-terminal fragments. Virology 269:18–25 [CrossRef]
    [Google Scholar]
  2. Ben-Porat T., Kaplan A. S. 1985; Molecular biology of pseudorabies virus. In The Herpesviruses pp 105–173 Edited by Roizman B. New York, NY: Plenum Publishing Corp;
    [Google Scholar]
  3. Britt W. J., Vugler L. G. 1989; Processing of the gp55/116 envelope glycoprotein complex (gB) of human cytomegalovirus. J Virol 63:403–410
    [Google Scholar]
  4. Bzik D. J., Fox B. A., DeLuca N. A., Person S. 1984; Nucleotide sequence of a region of the herpes simplex virus type 1 gB glycoprotein gene: mutations affecting rate of virus entry and cell fusion. Virology 137:185–190 [CrossRef]
    [Google Scholar]
  5. Claesson-Welsh L., Spear P. G. 1986; Oligomerization of herpes simplex virus glycoprotein B. J Virol 60:803–806
    [Google Scholar]
  6. de Haan C. A., Stadler K., Godeke G. J., Bosch B. J., Rottier P. J. 2004; Cleavage inhibition of the murine coronavirus spike protein by a furin-like enzyme affects cell-cell but not virus-cell fusion. J Virol 78:6048–6054 [CrossRef]
    [Google Scholar]
  7. Gong M., Ooka T., Matsuo T., Kieff E. 1987; Epstein-Barr virus glycoprotein homologous to herpes simplex virus gB. J Virol 61:499–508
    [Google Scholar]
  8. Hampl H., Ben-Porat T., Ehrlicher L., Habermehl K. O., Kaplan A. S. 1984; Characterization of the envelope proteins of pseudorabies virus. J Virol 52:583–590
    [Google Scholar]
  9. Harlow E., Lane D. 1988; Immunoaffinity purification. In Antibodies: a Laboratory Manual pp 511–552 Cold Spring Harbor, NY: Cold Spring Harbor Laboratory;
    [Google Scholar]
  10. Jean F., Thomas L., Molloy S. S., Liu G., Jarvis M. A., Nelson J. A., Thomas G. 2000; A protein-based therapeutic for human cytomegalovirus infection. Proc Natl Acad Sci U S A 97:2864–2869 [CrossRef]
    [Google Scholar]
  11. Johannsen E., Luftig M., Chase M. R., Weicksel S., Cahir-McFarland E., Illanes D., Sarracino D., Kieff E. 2004; Proteins of purified Epstein-Barr virus. Proc Natl Acad Sci U S A 101:16286–16291 [CrossRef]
    [Google Scholar]
  12. Klenk H. D., Rott R., Orlich M., Blodorn J. 1975; Activation of influenza A viruses by trypsin treatment. Virology 68:426–443 [CrossRef]
    [Google Scholar]
  13. Klupp B. G., Visser N., Mettenleiter T. C. 1992; Identification and characterization of pseudorabies virus glycoprotein H. J Virol 66:3048–3055
    [Google Scholar]
  14. Klupp B. G., Nixdorf R., Mettenleiter T. C. 2000; Pseudorabies virus glycoprotein M inhibits membrane fusion. J Virol 74:6760–6768 [CrossRef]
    [Google Scholar]
  15. Kopp A., Blewett E., Misra V., Mettenleiter T. C. 1994; Proteolytic cleavage of bovine herpesvirus 1 (BHV-1) glycoprotein gB is not necessary for its function in BHV-1 or pseudorabies virus. J Virol 68:1667–1674
    [Google Scholar]
  16. Laemmli U. K. 1970; Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680–685 [CrossRef]
    [Google Scholar]
  17. Meredith D. M., Stocks J. M., Whittaker G. R., Halliburton I. W., Snowden B. W., Killington R. A. 1989; Identification of the gB homologues of equine herpesvirus types 1 and 4 as disulphide-linked heterodimers and their characterization using monoclonal antibodies. J Gen Virol 70:1161–1172 [CrossRef]
    [Google Scholar]
  18. Mettenleiter T. C., Spear P. G. 1994; Glycoprotein gB (gII) of pseudorabies virus can functionally substitute for glycoprotein gB in herpes simplex virus type 1. J Virol 68:500–504
    [Google Scholar]
  19. Nagai Y., Ogura H., Klenk H. 1976; Studies on the assembly of the envelope of Newcastle disease virus. Virology 69:523–538 [CrossRef]
    [Google Scholar]
  20. Okazaki K., Kida H. 2004; A synthetic peptide from a heptad repeat region of herpesvirus glycoprotein B inhibits virus replication. J Gen Virol 85:2131–2137 [CrossRef]
    [Google Scholar]
  21. Okazaki K., Honda E., Minetoma T., Kumagai T. 1986; Mechanisms of neutralization by monoclonal antibodies to different antigenic sites on the bovine herpesvirus type 1 glycoproteins. Virology 150:260–264 [CrossRef]
    [Google Scholar]
  22. Okazaki K., Honda E., Minetoma T., Kumagai T. 1987; Intracellular localization and transport of three different bovine herpesvirus type 1 glycoproteins involved in neutralization. Arch Virol 92:17–26 [CrossRef]
    [Google Scholar]
  23. Okazaki K., Kumagai T., Honda E., Okazaki K. 1990; The immunodominant glycoprotein complex of equid herpesvirus 1 (EHV-1) and the counterpart of EHV-4. Nippon Juigaku Zasshi 52:1127–1130 [CrossRef]
    [Google Scholar]
  24. Okazaki K., Matsuzaki T., Sugahara Y., Okada J., Hasebe K., Iwamura Y., Ohnishi M., Kanno T., Shimizu M. other authors 1991; BHV-1 adsorption is mediated by the interaction of glycoprotein gIII with heparinlike moiety on the cell surface. Virology 181:666–670 [CrossRef]
    [Google Scholar]
  25. Okazaki K., Kanno T., Honda E., Kono Y. 1993; Hemadsorptive activity of transfected COS-7 cells expressing BHV-1 glycoprotein gIII. Virology 193:1024–1027 [CrossRef]
    [Google Scholar]
  26. Ortmann D., Ohuchi M., Angliker H., Shaw E., Garten W., Klenk H. D. 1994; Proteolytic cleavage of wild type and mutants of the F protein of human parainfluenza virus type 3 by two subtilisin-like endoproteases, furin and Kex2. J Virol 68:2772–2776
    [Google Scholar]
  27. Rauh I., Mettenleiter T. C. 1991; Pseudorabies virus glycoproteins gII and gp50 are essential for virus penetration. J Virol 65:5348–5356
    [Google Scholar]
  28. Richards R. M., Douglas L. R., Schiller J. T., Day P. M. 2006; Cleavage of the papillomavirus minor capsid protein, L2, at a furin consensus site is necessary for infection. Proc Natl Acad Sci U S A 103:1522–1527 [CrossRef]
    [Google Scholar]
  29. Ross L. J., Sanderson M., Scott S. D., Binns M. M., Doel T., Milne B. 1989; Nucleotide sequence and characterization of the Marek's disease virus homologue of glycoprotein B of herpes simplex virus. J Gen Virol 70:1789–1804 [CrossRef]
    [Google Scholar]
  30. Strive T., Borst E., Messerle M., Radsak K. 2002; Proteolytic processing of human cytomegalovirus glycoprotein B is dispensable for viral growth in culture. J Virol 76:1252–1264 [CrossRef]
    [Google Scholar]
  31. Takahashi S., Kasai K., Hatsuzawa K., Kitamura N., Misumi Y., Ikehara Y., Murakami K., Nakayama K. 1993; A mutation of furin causes the lack of precursor-processing activity in human colon carcinoma LoVo cells. Biochem Biophys Res Commun 195:1019–1026 [CrossRef]
    [Google Scholar]
  32. Turner A., Bruun B., Minson T., Browne H. 1998; Glycoproteins gB, gD, and gH/gL of herpes simplex virus type 1 are necessary and sufficient to mediate membrane fusion in a Cos cell transfection system. J Virol 72:873–875
    [Google Scholar]
  33. van Drunen Littel-van den Hurk S., Babiuk L. A. 1986; Synthesis and processing of bovine herpesvirus 1 glycoproteins. J Virol 59:401–410
    [Google Scholar]
  34. Vey M., Schafer W., Reis B., Ohuchi R., Britt W., Garten W., Klenk H. D., Radsak K. 1995; Proteolytic processing of human cytomegalovirus glycoprotein B (gpUL55) is mediated by the human endoprotease furin. Virology 206:746–749 [CrossRef]
    [Google Scholar]
  35. Volchkov V. E., Feldmann H., Volchkova V. A., Klenk H. D. 1998; Processing of the Ebola virus glycoprotein by the proprotein convertase furin. Proc Natl Acad Sci U S A 95:5762–5767 [CrossRef]
    [Google Scholar]
  36. Whealy M. E., Robbins A. K., Enquist L. W. 1990; The export pathway of the pseudorabies virus gB homolog gII involves oligomer formation in the endoplasmic reticulum and protease processing in the Golgi apparatus. J Virol 64:1946–1955
    [Google Scholar]
  37. Whealy M. E., Card J. P., Meade R. P., Robbins A. K., Enquist L. W. 1991; Effect of brefeldin A on alphaherpesvirus membrane protein glycosylation and virus egresss. J Virol 65:1066–1081
    [Google Scholar]
  38. Wolfer U., Kruft V., Sawitzky D., Hampl H., Wittmann-Liebold B., Habermehl K.-O. 1990; Processing of pseudorabies virus glycoprotein gII. J Virol 64:3122–3125
    [Google Scholar]
  39. Zhang X., Fugere M., Day R., Kielian M. 2003; Furin processing and proteolytic activation of Semliki Forest virus. J Virol 77:2981–2989 [CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.82610-0
Loading
/content/journal/jgv/10.1099/vir.0.82610-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error